John Miao

• 15+ years of drug discovery experience in the pharmaceutical industry in the area of Oncology, Immunology, Clinical Pharmacology, and focused on gene immunotherapy for cancers (melanoma, breast cancer, glioblastoma) and novel biologics for cardiovascular disease (pulmonary artery hypertension). • Monitoring and managing the conduct of ongoing or new Phase II & III clinical trials for investigational drugs. • Fully engaged in the development of clinical protocols to support the company’s product strategy, data collection and management, and final reports development in compliance with appropriate SOPs, regulatory and medical standards. • Planning clinical trials (design, operational plans, settings) based on clinical development strategies. • Identification of investigators who can assist in the development of investigational and marketed drugs and actively engaging with KOLs, investigators, coordinators and other clinical trial site personnel to drive study enrollment.